Investment Rating - The report does not explicitly state an investment rating for the cardiovascular health food industry in China Core Insights - The cardiovascular health food industry in China is experiencing rapid growth driven by an aging population and increasing health awareness among consumers. The potential for growth in cardiovascular health food products is expected to be rapidly released with policy support [3][6] - The demand for cardiovascular health food products is rising as the public becomes more aware of the health risks associated with hypertension, hyperlipidemia, and hyperglycemia, which are major risk factors for cardiovascular diseases [4][18] - The industry is characterized by a dual-track registration and filing system for health food products, which enhances the flexibility of new product launches and standardizes the industry [21][23] Summary by Sections Industry Overview - Cardiovascular diseases, including coronary heart disease and stroke, are prevalent, with "three highs" (hypertension, hyperlipidemia, and hyperglycemia) being significant risk factors [15][16] - The industry has evolved from disorderly to orderly, with improved regulatory frameworks and market standardization, currently in a phase of high-quality development [21][22] Market Size - The market size for cardiovascular health food products in China grew from 142.56 billion yuan in 2019 to 158.39 billion yuan in 2023, with projections to reach 189.89 billion yuan by 2028 [27][28] - The middle-aged and elderly markets are expanding due to increased health awareness and the aging population, respectively [26][29] Industry Chain Analysis - The industry chain consists of upstream raw material suppliers, midstream manufacturers, and downstream sales channels [33] - Traditional Chinese medicine is recognized as a significant source of raw materials for cardiovascular health products, with ingredients like ginseng, astragalus, and hawthorn being commonly used [36][38] Competitive Landscape - The industry is competitive, with a low concentration of market share and significant product homogeneity. Companies compete on product quality, innovation, brand building, and market positioning [46][47] - The growth potential of companies in this sector is influenced by their ability to innovate and control costs effectively [47]
2024年中国心脑血管健康保健食品行业概览报告
头豹研究院·2024-09-24 12:31